Researcher
Wim Maes
- Disciplines:Adaptive immunology, Applied immunology
Affiliations
- Chemistry, Kulak Kortrijk Campus (Department)
Member
From1 Sep 2010 → Today - Faculty of Science, Kulak Kortrijk Campus (Faculty)
Member
From1 Feb 2010 → 31 Aug 2010 - Allergy and Clinical Immunology Research Group (Division)
Member
From1 Nov 2004 → 31 Jan 2010
Projects
1 - 5 of 5
- Flow cytometer for the Interdisciplinary Research Facility Life Sciences at Campus Kulak KortrijkFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Rapid and easy-to-perform FO-SPR-based assays for VWF antigen and functionality and insights into the vaccine-induced adaptive immune response against SARS-CoV-2From1 Aug 2019 → 25 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Investigation of the role of GARP by using cell specific knockout miceFrom1 Oct 2013 → 12 Sep 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- The function of LRRC32 in thrombosis, haemostasis and regulatory T cell homeostasisFrom1 Jan 2013 → 31 Dec 2016Funding: FWO research project
- Development of advanced humanized mice as innovative technology platform for the generation of human antibodies.From1 Jan 2012 → 31 Dec 2014Funding: FWO research grant KAN
Publications
1 - 10 of 26
- Complementarity determining regions in SARS-CoV-2 hybrid immunity(2023)
Authors: Glynis Frans, Jonas De Leeuw, Wim Maes, Bas Calcoen, Nick Geukens, Rita Derua, Pieter Vermeersch, Sebastien Carpentier, Xavier Bossuyt
- Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model(2022)
Authors: Maya Imbrechts, Wim Maes, Louanne Ampofo, Nathalie Van den Berghe, Bas Calcoen, Winnie Kerstens, Madina Rasulova, Sam Noppen, Rana Abdelnabi, Piet Maes, et al.
- High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium(2022)
Authors: Bas Calcoen, Winnie Kerstens, Maya Imbrechts, Thomas Vercruysse, Kai Dallmeier, Johan Van Weyenbergh, Piet Maes, Xavier Bossuyt, Hendrik Jan Thibaut, Karen Vanhoorelbeke, et al.
- Innovative FO-SPR Label-free Strategy for Detecting Anti-RBD Antibodies in COVID-19 Patient Serum and Whole Blood(2022)
Authors: Karen Leirs, Wim Maes, Maya Imbrechts, Katrien Lagrou, Nick Geukens, Jeroen Lammertyn, Dragana Spasic
Pages: 477 - 487 - Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer(2020)
Authors: Elien Vermeersch, Wim Maes, Hans Deckmyn
- The senotherapeutic nicotinamide riboside raises platelet nicotinamide adenine dinucleotide levels but cannot prevent storage lesion(2020)
Authors: Wim Maes, Karen Vanhoorelbeke
Pages: 165 - 174 - Deletion of GARP on mouse regulatory T cells is not sufficient to inhibit the growth of transplanted tumors(2018)
Authors: Elien Vermeersch, Conny Gysemans, Karen Vanhoorelbeke, Simon De Meyer, Wim Maes, Hans Deckmyn
Pages: 129 - 133 - Investigation of the role of GARP by using cell specific knockout mice(2018)
Authors: Elien Vermeersch, Hans Deckmyn, Claudia Tersteeg, Wim Maes
- Pretargeted PET Imaging Using a Bioorthogonal 18F‑Labeled trans- Cyclooctene in an Ovarian Carcinoma Model(2017)
Authors: Sarah Belderbos, Frederik Cleeren, Wim Maes, Michel Koole, Alfons Verbruggen, Uwe Himmelreich, Nick Geukens, Guy Bormans
Pages: 2915 - 2920 - The role of platelet and endothelial GARP in thrombosis and hemostasis(2017)
Authors: Elien Vermeersch, Frederik Denorme, Wim Maes, Simon De Meyer, Karen Vanhoorelbeke, Hans Deckmyn, Claudia Tersteeg